Living donor liver transplantation (LDLT) has been controversial since its inception. Begun
in response to deceased donor organ shortage and waiting list mortality, LDLT was initiated …

Liver transplantation for hepatic malignancies has emerged as a well‐documented and
proven treatment modality. However, early unsatisfactory results emphasized that only a …

Importance Despite the acceptance of living-donor liver transplant (LDLT) as a lifesaving
procedure for end-stage liver disease, it remains underused in the United States …

Background & Aims: Reports of complications among adult right hepatic lobe donors have
been limited to single centers. The rate and severity of complications in living donors were …

Hepatic steatosis is a common condition, the prevalence of which is increasing along with
non-alcoholic fatty liver disease (NAFLD). Currently, the most accurate noninvasive imaging …

National liver transplantation (LT) volume has declined since 2006, in part because of
worsening donor organ quality. Trends that degrade organ quality are expected to continue …

Background & Aims: More than 2000 adult-to-adult living donor liver transplantations (LDLT)
have been performed in the United States, yet the potential benefit to liver transplant …

Abstract In the United States, living donor liver transplantation (LDLT) is limited to transplant
centers with specific experience. However, the impact of recipient characteristics on …

Adult-to-adult living donor liver transplantation (A2ALDLT), outside of Asia, remains an
important yet underutilized gift of life. For patients with end-stage liver disease, A2ALDLT is …

LDLT has become established as a viable strategy to ameliorate the organ shortage
experienced by centers around the world. Improved understanding of this technique has …